Nephrada · IGAN · United Kingdom · Academic nephrologist · captured by Dr. Anna Becker on 07 Jul 2026 · reviewed by Dr. Elena Moretti on 09 Jul 2026
Verbatim as captured; never edited
Academic nephrologist at Christie NHS Foundation Trust raised steroid-sparing strategies during a payer / hta meeting. They indicated this influences their current prescribing approach.
Human-approved by Dr. Elena Moretti on 09 Jul 2026
Steroid-sparing strategies: gap in current materials reported by academic nephrologist (GB).
helixor-private-llm-2026.05 · generated 07 Jul 2026, 10:00 UTC
AI summary
Steroid-sparing strategies raised by academic nephrologist; relevant for Market Access.
Source spans used by the model
Academic nephrologist at Christie NHS Foundation Trust raised steroid-sparing strategies during a payer / hta meeting. They indicated this influences their current prescribing approach.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Access and reimbursement | Access and reimbursement |
| Function | Market Access | Market Access |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 1 | 15% | 3.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 4 | 10% | 8.0 |
| Actionability | 5 | 10% | 10.0 |
| Confidence | 3 | 5% | 3.0 |
| Breadth of occurrence | 3 | 5% | 3.0 |
| Total | Medium 59 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
07 Jul 2026 · Dr. Gabriel Yamamoto, Christie NHS Foundation Trust · MSL Dr. Anna Becker
Insight
Reviewed 09 Jul 2026 by Dr. Elena Moretti
Action
Initiative
Decision
Outcome
Closure